Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'striatal membranes' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 93 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Gevaerd, MS; Takahashi, RN; Silveira, R; Da Cunha, C
      Caffeine reverses the memory disruption induced by intra-nigral MPTP-injection in rats

      BRAIN RESEARCH BULLETIN
    2. Powell, KR; Iuvone, PM; Holtzman, SG
      The role of dopamine in the locomotor stimulant effects and tolerance to these effects of caffeine

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    3. Ishiwata, K; Ogi, N; Shimada, J; Nonaka, H; Tanaka, A; Suzuki, F; Senda, M
      Further characterization of a CNS adenosine A(2a) receptor ligand [C-11]KF18446 with in vitro autoradiography and in vivo tissue uptake

      ANNALS OF NUCLEAR MEDICINE
    4. Olanrewaju, HA; Qin, W; Feoktistov, I; Scemama, JL; Mustafa, SJ
      Adenosine A(2A) and A(2B) receptors in cultured human and porcine coronaryartery endothelial cells

      AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
    5. Ishiwata, K; Noguchi, J; Wakabayashi, S; Shimada, J; Ogi, N; Nariai, T; Tanaka, A; Endo, K; Suzuki, F; Senda, M
      C-11-labeled KF18446: A potential central nervous system adenosine A(2a) receptor ligand

      JOURNAL OF NUCLEAR MEDICINE
    6. Klotz, KN
      Adenosine receptors and their ligands

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    7. Corera, AT; Costentin, J; Bonnet, JJ
      Binding of uptake blockers to the neuronal dopamine transporter: further investigation about cationic and anionic requirements

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    8. Wang, LJC; Berfield, JL; Kuhar, MJ; Carroll, FI; Reith, MEA
      RTI-76, an isothiocyanate derivative of a phenyltropane cocaine analog, asa tool for irreversibly inactivating dopamine transporter function in vitro

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    9. Lotharius, J; O'Malley, KL
      The Parkinsonism-inducing drug 1-methyl-4-phenylpyridinium triggers intracellular dopamine oxidation - A novel mechanism of toxicity

      JOURNAL OF BIOLOGICAL CHEMISTRY
    10. von Euler, M; Pham, TM; Hillefors, M; Bjelke, B; Henriksson, B; von Euler, G
      Inhalation of low concentrations of toluene induces persistent effects on a learning retention task, beam-walk performance, and cerebrocortical size in the rat

      EXPERIMENTAL NEUROLOGY
    11. Holtom, PE; Needham, PL; Bennett, GW; Aspley, S
      Chronic, but not acute, dosing of antipsychotic drugs alters neurotensin binding in rat brain regions

      BRITISH JOURNAL OF PHARMACOLOGY
    12. Nishi, N; Odagaki, Y; Koyama, T
      Pharmacological characterization of metabotropic glutamate receptor-mediated high-affinity GTPase activity in rat cerebral cortical membranes

      BRITISH JOURNAL OF PHARMACOLOGY
    13. Gessi, S; Varani, K; Merighi, S; Ongini, E; Borea, PA
      A(2A) adenosine receptors in human peripheral blood cells

      BRITISH JOURNAL OF PHARMACOLOGY
    14. Baures, PW; Pradhan, A; Ojala, WH; Gleason, WB; Mishra, RK; Johnson, RL
      Synthesis and dopamine receptor modulating activity of unsubstituted and substituted triproline analogues of L-prolyl-L-leucyl-glycinamide (PLG)

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    15. Casas, M; Prat, G; Robledo, P; Barbanoj, M; Kulisevsky, J; Jane, F
      Repeated co-administration of caffeine and bromocriptine prevents tolerance to the effects of caffeine in the turning behavior animal model

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    16. Tarazi, FI; Baldessarini, RJ
      Regional localization of dopamine and ionotropic glutamate receptor subtypes in striatolimbic brain regions

      JOURNAL OF NEUROSCIENCE RESEARCH
    17. Fleuranceau-Morel, P; Barrier, L; Fauconneau, B; Piriou, A; Huguet, F
      Origin of 4-hydroxynonenal incubation-induced inhibition of dopamine transporter and Na+/K+ adenosine triphosphate in rat striatal synaptosomes

      NEUROSCIENCE LETTERS
    18. Grondin, R; Bedard, PJ; Tahar, AH; Gregoire, L; Mori, A; Kase, H
      Antiparkinsonian effect of a new selective adenosine A(2A) receptor antagonist in MPTP-treated monkeys

      NEUROLOGY
    19. Geurts, M; Hermans, E; Maloteaux, JM
      Assessment of striatal D1 and D2 dopamine receptor-G protein coupling by agonist-induced [S-35]GTP gamma S binding

      LIFE SCIENCES
    20. Berfield, JL; Wang, LJC; Reith, MEA
      Which form of dopamine is the substrate for the human dopamine transporter: The cationic or the uncharged species?

      JOURNAL OF BIOLOGICAL CHEMISTRY
    21. Rothman, RB; Ayestas, MA; Dersch, CM; Baumann, MH
      Aminorex, fenfluramine, and chlorphentermine are serotonin transporter substrates - Implications for primary pulmonary hypertension

      CIRCULATION
    22. Kull, B; Ferre, S; Arslan, G; Svenningsson, P; Fuxe, K; Owman, C; Fredholm, BB
      Reciprocal interactions between adenosine A(2A) and dopamine D-2 receptorsin Chinese hamster ovary cells co-transfected with the two receptors

      BIOCHEMICAL PHARMACOLOGY
    23. MALLY J; STONE TW
      POTENTIAL OF ADENOSINE A(2A) RECEPTOR ANTAGONISTS IN THE TREATMENT OFMOVEMENT-DISORDERS

      CNS drugs
    24. BOJA JW; CARROLL FI; VAUGHAN RA; KOPAJTIC T; KUHAR MJ
      MULTIPLE BINDING-SITES FOR [I-125] RTI-121 AND OTHER COCAINE ANALOGS IN RAT FRONTAL CEREBRAL-CORTEX

      Synapse
    25. Varani, K; Gessi, S; Merighi, S; Ongini, E; Borea, PA
      Adenosine A(2a) receptors of human circulating blood elements

      DRUG DEVELOPMENT RESEARCH
    26. STRAZIELLE C; LALONDE R; AMDISS F; BOTEZ MI; HEBERT C; READER TA
      DISTRIBUTION OF DOPAMINE TRANSPORTERS IN BASAL GANGLIA OF CEREBELLAR ATAXIC MICE BY [I-125] RTI-121 QUANTITATIVE AUTORADIOGRAPHY

      Neurochemistry international
    27. POWELL KR; HOLTZMAN SG
      LACK OF NMDA RECEPTOR INVOLVEMENT IN CAFFEINE-INDUCED LOCOMOTOR STIMULATION AND TOLERANCE IN RATS

      Pharmacology, biochemistry and behavior
    28. BARALDI PG; CACCIARI B; SPALLUTO G; BERGONZONI M; DIONISOTTI S; ONGINI E; VARANI K; BOREA PA
      DESIGN, SYNTHESIS, AND BIOLOGICAL EVALUATION OF A 2ND-GENERATION OF PYRAZOLO[4,3-E]-1,2,4-TRIAZOLO[1,5-C]PYRIMIDINES AS POTENT AND SELECTIVE A(2A) ADENOSINE RECEPTOR ANTAGONISTS

      Journal of medicinal chemistry
    29. Napieralski, JA; Banks, RJA; Chesselet, MF
      Motor and somatosensory deficits following uni- and bilateral lesions of the cortex induced by aspiration or thermocoagulation in the adult rat

      EXPERIMENTAL NEUROLOGY
    30. Lezcano, NE; Salvatierra, NA; Celis, ME
      alpha-Melanotropin hormone inhibits the binding of [H-3]SCH 23390 to the dopamine D-1 receptor in vitro

      EUROPEAN JOURNAL OF PHARMACOLOGY
    31. SVENNINGSSON P; HALL H; SEDVALL G; FREDHOLM BB
      DISTRIBUTION OF ADENOSINE RECEPTORS IN THE POSTMORTEM HUMAN BRAIN - AN EXTENDED AUTORADIOGRAPHIC STUDY

      Synapse
    32. DELAMORA MP; FERRE S; FUXE K
      GABA-DOPAMINE RECEPTOR-RECEPTOR INTERACTIONS IN NEOSTRIATAL MEMBRANESOF THE RAT

      Neurochemical research
    33. LI XM; JANSSON A; FINNMAN UB; AGNATI LF; FUXE K
      POSSIBLE INVOLVEMENT OF G-PROTEINS IN THE REGULATION OF STRIATAL DOPAMINE D-2 RECEPTOR AFFINITY BY CHOLECYSTOKININ-OCTAPEPTIDE

      Neuroscience letters
    34. MISHRA RK; MARCOTTE ER; CHUGH A; BARLAS C; WHAN D; JOHNSON RL
      MODULATION OF DOPAMINE-RECEPTOR AGONIST-INDUCED ROTATIONAL BEHAVIOR IN 6-OHDA-LESIONED RATS BY A PEPTIDOMIMETIC ANALOG OF PRO-LEU-GLY-NH2 (PLG)

      Peptides
    35. SIDHU A; UH M; SELA S; WHITE BH; KIMURA K; PATEL S
      MOLECULAR AND STRUCTURAL DIFFERENCES BETWEEN RAT-BRAIN D-1 AND RENAL DA-1 DOPAMINE-RECEPTORS

      Neuroscience research
    36. FEOKTISTOV I; BIAGGIONI I
      ADENOSINE A(2B) RECEPTORS

      Pharmacological reviews
    37. SHANNON HE; SHEARDOWN MJ; BYMASTER FP; CALLIGARO DO; DELAPP NW; GIDDA J; MITCH CH; SAWYER BD; STENGEL PW; WARD JS; WONG DT; OLESEN PH; SUZDAK PD; SAUERBERG P; SWEDBERG MDB
      PHARMACOLOGY OF BUTYLTHIO[2.2.2] (LY297802 NNC11-1053) - A NOVEL ANALGESIC WITH MIXED MUSCARINIC RECEPTOR AGONIST AND ANTAGONIST ACTIVITY/

      The Journal of pharmacology and experimental therapeutics
    38. SCHOEMAKER H; CLAUSTRE Y; FAGE D; ROUQUIER L; CHERGUI K; CURET O; OBLIN A; GONON F; CARTER C; BENAVIDES J; SCATTON B
      NEUROCHEMICAL CHARACTERISTICS OF AMISULPRIDE, AN ATYPICAL DOPAMINE D-2 D-3 RECEPTOR ANTAGONIST WITH BOTH PRESYNAPTIC AND LIMBIC SELECTIVITY/

      The Journal of pharmacology and experimental therapeutics
    39. VARANI K; GESSI S; DALPIAZ A; ONGINI E; BOREA PA
      CHARACTERIZATION OF A(2A) ADENOSINE RECEPTORS IN HUMAN LYMPHOCYTE MEMBRANES BY [H-3] SCH-58261 BINDING

      British Journal of Pharmacology
    40. DIONISOTTI S; ONGINI E; ZOCCHI C; KULL B; ARSLAN G; FREDHOLM BB
      CHARACTERIZATION OF HUMAN A(2A) ADENOSINE RECEPTORS WITH THE ANTAGONIST RADIOLIGAND [H-3] SCH-58261

      British Journal of Pharmacology
    41. FLAGMEYER I; HAAS HL; STEVENS DR
      ADENOSINE A(1) RECEPTOR-MEDIATED DEPRESSION OF CORTICOSTRIATAL AND THALAMOSTRIATAL GLUTAMATERGIC SYNAPTIC POTENTIALS IN-VITRO

      Brain research
    42. ODAGAKI Y; NISHI N; KOYAMA T
      LACK OF INTERFERING EFFECTS OF LITHIUM ON RECEPTOR G-PROTEIN COUPLINGIN HUMAN PLATELET AND RAT-BRAIN MEMBRANES

      Biological psychiatry
    43. SINGH AN; BARLAS C; SINGH S; FRANKS P; MISHRA RK
      A NEUROCHEMICAL BASIS FOR THE ANTIPSYCHOTIC ACTIVITY OF LOXAPINE - INTERACTIONS WITH DOPAMINE D-1, D-2, D-4 AND SEROTONIN 5-HT2 RECEPTOR SUBTYPES

      Journal of psychiatry & neuroscience
    44. KOUTSILIERI E; KORNHUBER J; DEGEN HJ; LESCH KP; SOPPER S; TERMEULEN V; RIEDERER P
      U-373 MG GLIOBLASTOMA AND IMR-32 NEUROBLASTOMA CELL-LINES EXPRESS THEDOPAMINE AND VESICULAR MONOAMINE TRANSPORTERS

      Journal of neuroscience research
    45. POPOLI P; GIMENEZLLORT L; PEZZOLA A; REGGIO R; MARTINEZ E; FUXE K; FERRE S
      ADENOSINE A(1) RECEPTOR BLOCKADE SELECTIVELY POTENTIATES THE MOTOR EFFECTS INDUCED BY DOPAMINE D-1 RECEPTOR STIMULATION IN RODENTS

      Neuroscience letters
    46. NORLEN M; ALLARD P
      REDUCTION IN NUMBER OF DOPAMINE UPTAKE SITES BUT UNCHANGED NUMBER OF PIPERAZINE-ACCEPTOR CYP450IID6 BINDING-SITES IN THE HUMAN CAUDATE-NUCLEUS IN AGING/

      Neuroscience letters
    47. KUROKAWA M; SHIOZAKI S; NONAKA H; KASE H; NAKAMURA J; KUWANA Y
      IN-VIVO REGULATION OF ACETYLCHOLINE-RELEASE VIA ADENOSINE A(1) RECEPTOR IN RAT CEREBRAL-CORTEX

      Neuroscience letters
    48. ONGINI E; DIONISOTTI S; MORELLI M; FERRE S; SVENNINGSSON P; FUXE K; FREDHOLM BB
      NEUROPHARMACOLOGY OF THE ADENOSINE A(2A) RECEPTORS

      Drug development research
    49. DAVAL JL; NICOLAS F; DORIAT JF
      ADENOSINE PHYSIOLOGY AND PHARMACOLOGY - HOW ABOUT A(2) RECEPTORS

      Pharmacology & therapeutics
    50. NAPIERALSKI JA; BUTLER AK; CHESSELET MF
      ANATOMICAL AND FUNCTIONAL EVIDENCE FOR LESION-SPECIFIC SPROUTING OF CORTICOSTRIATAL INPUT IN THE ADULT-RAT

      Journal of comparative neurology
    51. NORRIS PJ; HARDWICK JP; EMSON PC
      REGIONAL DISTRIBUTION OF CYTOCHROME-P450 2D1 IN THE RAT CENTRAL-NERVOUS-SYSTEM

      Journal of comparative neurology
    52. POPOLI P; FERRE S; PEZZOLA A; REGGIO R; DECAROLIS AS; FUXE K
      STIMULATION OF ADENOSINE A(1) RECEPTORS PREVENTS THE EEG AROUSAL DUE TO DOPAMINE D-1 RECEPTOR ACTIVATION IN RABBITS

      European journal of pharmacology
    53. KAFKA SH; CORBETT R
      SELECTIVE ADENOSINE A(2A) RECEPTOR DOPAMINE D-2 RECEPTOR INTERACTIONSIN ANIMAL-MODELS OF SCHIZOPHRENIA

      European journal of pharmacology
    54. ZAVITSANOU K; MITSACOS A; GIOMPRES P; KOUVELAS ED
      CHANGES IN [H-3] AMPA AND [H-3] KAINATE BINDING IN RAT CAUDATE-PUTAMEN AND NUCLEUS-ACCUMBENS AFTER 6-HYDROXYDOPAMINE LESIONS OF THE MEDIAL FOREBRAIN-BUNDLE - AN AUTORADIOGRAPHIC STUDY

      Brain research
    55. ONGINI E; FREDHOLM BB
      PHARMACOLOGY OF ADENOSINE A(2A) RECEPTORS

      Trends in pharmacological sciences
    56. HILLEFORSBERGLUND M; LIU Y; VONEULER G
      PERSISTENT, SPECIFIC AND DOSE-DEPENDENT EFFECTS OF TOLUENE EXPOSURE ON DOPAMINE D-2 AGONIST BINDING IN THE RAT CAUDATE-PUTAMEN

      Toxicology
    57. LAIHINEN AO; RINNE JO; NAGREN KA; LEHIKOINEN PK; OIKONEN VJ; RUOTSALAINEN UH; RUOTTINEN HM; RINNE UK
      PET STUDIES ON BRAIN MONOAMINE TRANSPORTERS WITH CARBON-11-BETA-CIT IN PARKINSONS-DISEASE

      The Journal of nuclear medicine
    58. ELWAN MA; SOLIMAN MRI
      ALTERATION OF D-1 AND D-2 DOPAMINERGIC RECEPTOR KINETICS IN SPECIFIC RAT-BRAIN REGIONS FOLLOWING REPEATED ADMINISTRATION OF OPIATES

      Pharmacology
    59. BOJA JW; CADET JL; KOPAJTIC TA; LEVER J; SELTZMAN HH; WYRICK CD; LEWIN AH; ABRAHAM P; CARROLL FI
      SELECTIVE LABELING OF THE DOPAMINE TRANSPORTER BY THE HIGH-AFFINITY LIGAND ETA-(4-[I-125]IODOPHENYL)TROPANE-2-BETA-CARBOXYLIC ACID ISOPROPYL ESTER

      Molecular pharmacology
    60. GARRETT BE; HOLTZMAN SG
      DOES ADENOSINE RECEPTOR BLOCKADE MEDIATE CAFFEINE-INDUCED ROTATIONAL BEHAVIOR

      The Journal of pharmacology and experimental therapeutics
    61. WU YN; MERCURI NB; JOHNSON SW
      PRESYNAPTIC INHIBITION OF GAMMA-AMINOBUTYRIC ACID(B)-MEDIATED SYNAPTIC CURRENT BY ADENOSINE RECORDED IN-VITRO IN MIDBRAIN DOPAMINE NEURONS

      The Journal of pharmacology and experimental therapeutics
    62. SILVERTHORN ML; DERSCH CM; BAUMANN MH; CADET JL; PARTILLA JS; RICE KC; CARROLL FI; BECKETTS KM; BROCKINGTON A; ROTHMAN RB
      STUDIES OF THE BIOGENIC-AMINE TRANSPORTERS .5. DEMONSTRATION OF 2 BINDING-SITES FOR THE COCAINE ANALOG [I-125] RTI-55 ASSOCIATED WITH THE 5-HT TRANSPORTER IN RAT-BRAIN MEMBRANES

      The Journal of pharmacology and experimental therapeutics
    63. HILLEFORSBERGLUND M; HEDLUND PB; VONEULER G
      EFFECTS OF CGS-21680 IN-VIVO ON DOPAMINE D-2 AGONIST BINDING IN THE RAT-BRAIN

      Brain research
    64. GORDON I; WEIZMAN R; REHAVI M
      [H-3] GBR-12935 LABELS MAINLY THE PIPERAZINE ACCEPTOR SITE IN THE RATPREFRONTAL CORTEX

      Brain research
    65. MINELLI A; MISCETTI P; ALLEGRUCCI C; MEZZASOMA I
      EVIDENCE OF A1 ADENOSINE RECEPTOR ON EPIDYDIMAL BOVINE SPERMATOZOA

      Archives of biochemistry and biophysics
    66. NONAKA H; ICHIMURA M; TAKEDA M; NONAKA Y; SHIMADA J; SUZUKI F; YAMAGUCHI K; KASE H
      KF17837 4-DIMETHOXYSTYRYL)-1,3-DIPROPYL-7-METHYLXANTHINE), A POTENT AND SELECTIVE ADENOSINE A(2) RECEPTOR ANTAGONIST

      European journal of pharmacology. Molecular pharmacology section
    67. DEGANDARIAS JM; ECHEVARRIA E; SERRANO R; IRAZUSTA J; CASIS L
      EFFECT OF SUBACUTE TOLUENE ADMINISTRATION ON THE ENKEPHALINERGIC NEUROMODULATORY SYSTEM IN RATS AND PROTECTIVE ACTION OF GANGLIOSIDE TREATMENTS

      Toxicology and industrial health
    68. MENG F; XIE GX; CHALMERS D; MORGAN C; WATSON SJ; AKIL H
      CLONING AND EXPRESSION OF THE A(2A) ADENOSINE RECEPTOR FROM GUINEA-PIG BRAIN

      Neurochemical research
    69. NONAKA H; MORI A; ICHIMURA M; SHINDOU T; YANAGAWA K; SHIMADA J; KASE H
      BINDING OF [H-3] KF17837S, A SELECTIVE ADENOSINE A(2) RECEPTOR ANTAGONIST, TO RAT-BRAIN MEMBRANES

      Molecular pharmacology
    70. YUE JL; UEDA H; MISU Y
      EVIDENCE FOR A DOPAMINE-RECEPTOR SUBTYPE SENSITIVE TO COMBINATION OF D1 WITH D2 ANTAGONIST IN MEASUREMENT OF G-PROTEIN ACTIVITY USING RAT STRIATAL MEMBRANES

      Life sciences
    71. ROTHMAN RB; CADET JL; AKUNNE HC; SILVERTHORN ML; BAUMANN MH; CARROLL FI; RICE KC; DECOSTA BR; PARTILLA JS; WANG JB; UHL G; GLOWA JR; DERSCH CM
      STUDIES OF THE BIOGENIC-AMINE TRANSPORTERS .4. DEMONSTRATION OF A MULTIPLICITY OF BINDING-SITES IN RAT CAUDATE MEMBRANES FOR THE COCAINE ANALOG [I-125] RTI-55

      The Journal of pharmacology and experimental therapeutics
    72. ALLARD P; DANIELSSON M; PAPWORTH K; MARCUSSON JO
      [H-3] GBR-12935 BINDING TO HUMAN CEREBRAL-CORTEX IS NOT TO DOPAMINE UPTAKE SITES

      Journal of neurochemistry
    73. ALLARD P; MARCUSSON JO; ROSS SB
      [H-3] GBR-12935 BINDING TO CYTOCHROME-P450 IN THE HUMAN BRAIN

      Journal of neurochemistry
    74. DAWSON VL; HSU CY; LIU TH; DAWSON TM; WAMSLEY JK
      RECEPTOR ALTERATIONS IN SUBCORTICAL STRUCTURES AFTER BILATERAL MIDDLECEREBRAL-ARTERY INFARCTION OF THE CEREBRAL-CORTEX

      Experimental neurology
    75. KANDA T; SHIOZAKI S; SHIMADA J; SUZUKI F; NAKAMURA J
      KF17837 - A NOVEL SELECTIVE ADENOSINE A(2A) RECEPTOR ANTAGONIST WITH ANTICATALEPTIC ACTIVITY

      European journal of pharmacology
    76. HARADA Y; HARA H; SUKAMOTO T
      RECEPTOR-BINDING PROFILES OF KB-5492, A NOVEL ANTIULCER AGENT, AT SIGMA-RECEPTORS IN GUINEA-PIG BRAIN

      European journal of pharmacology
    77. PEACHEY JA; HOURANI SMO; KITCHEN I
      THE BINDING OF 1,3-[H-3]-DIPROPYL-8-CYCLOPENTYLXANTHINE TO ADENOSINE A(1) RECEPTORS IN RAT SMOOTH-MUSCLE PREPARATIONS

      British Journal of Pharmacology
    78. DIONISOTTI S; CONTI A; SANDOLI D; ZOCCHI C; GATTA F; ONGINI E
      EFFECTS OF THE NEW A(2) ADENOSINE RECEPTOR ANTAGONIST 8FB-PTP, AN 8 SUBSTITUTED PYRAZOLO-TRIAZOLO-PYRIMIDINE, ON IN-VITRO FUNCTIONAL MODELS

      British Journal of Pharmacology
    79. RITZ MC; MANTIONE CR; LONDON ED
      SPERMINE INTERACTS WITH COCAINE BINDING-SITES ON DOPAMINE TRANSPORTERS

      Psychopharmacology
    80. SOMMERMEYER H; DOMPERT WU; GLASER T
      SIGNALING VIA RAT DOPAMINE D(2)-RECEPTORS EXPRESSED IN MOUSE FIBROBLASTS IS NOT INFLUENCED BY COMPOUNDS BINDING TO THE SIGMA SITES OF THESECELLS

      Cellular signalling
    81. ZOLI M; AGNATI LF; HEDLUND PB; LI XM; FERRE S; FUXE K
      RECEPTOR-RECEPTOR INTERACTIONS AN INTEGRATIVE MECHANISM IN NERVE-CELLS

      Molecular neurobiology
    82. KOSTRZEWA RM; KASTIN AJ
      TYR-MIF-1 ATTENUATES DEVELOPMENT OF TOLERANCE TO SPIPERONE-INDUCED CATALEPSY IN RATS

      Brain research bulletin
    83. LI XM; FINNMAN UB; VONEULER G; HEDLUND PB; FUXE K
      NEUROMEDIN N IS A POTENT MODULATOR OF DOPAMINE D(2) RECEPTOR AGONIST BINDING IN RAT NEOSTRIATAL MEMBRANES

      Neuroscience letters
    84. AUGOOD SJ; WESTMORE K; MCKENNA PJ; EMSON PC
      COEXPRESSION OF DOPAMINE TRANSPORTER MESSENGER-RNA AND TYROSINE-HYDROXYLASE MESSENGER-RNA IN VENTRAL MESENCEPHALIC NEURONS

      Molecular brain research
    85. LORENZEN A; FUSS M; VOGT H; SCHWABE U
      MEASUREMENT OF GUANINE-NUCLEOTIDE-BINDING PROTEIN-ACTIVATION BY A1 ADENOSINE RECEPTOR AGONISTS IN BOVINE BRAIN MEMBRANES - STIMULATION OF GUANOSINE-5'-O-(3-[S-35]THIO)TRIPHOSPHATE BINDING

      Molecular pharmacology
    86. STELLA L; BERRINO L; MAIONE S; DENOVELLIS V; ROSSI F
      CARDIOVASCULAR EFFECTS OF ADENOSINE AND ITS ANALOGS IN ANESTHETIZED RATS

      Life sciences
    87. KARBON EW; ABREU ME; ERICKSON RH; KAISER C; NATALIE KJ; CLISSOLD DB; BOROSKY S; BAILEY M; MARTIN LA; PONTECORVO MJ; ENNA SJ; FERKANY JW
      NPC-16377, A POTENT AND SELECTIVE SIGMA-LIGAND .1. RECEPTOR-BINDING, NEUROCHEMICAL AND NEUROENDOCRINE PROFILE

      The Journal of pharmacology and experimental therapeutics
    88. MARTIN PL; POTTS AA; SYKES AM; MCKENNA DG
      (+ -)-N6-ENDONORBORNAN-2-YL-9-METHYLADENINE (N-0861) AND ITS ENANTIOMERS - SELECTIVE ANTAGONISTS OF ADENOSINE-A1-RECEPTORS IN GUINEA-PIG ISOLATED ATRIA/

      The Journal of pharmacology and experimental therapeutics
    89. MORISSETTE M; DIPAOLO T
      EFFECT OF CHRONIC ESTRADIOL AND PROGESTERONE TREATMENTS OF OVARIECTOMIZED RATS ON BRAIN DOPAMINE UPTAKE SITES

      Journal of neurochemistry
    90. NONAKA Y; SHIMADA J; NONAKA H; KOIKE N; AOKI N; KOBAYASHI H; KASE H; YAMAGUCHI K; SUZUKI F
      PHOTOISOMERIZATION OF A POTENT AND SELECTIVE ADENOSINE-A(2) ANTAGONIST, -DIPROPYL-8-(3,4-DIMETHOXYSTYRYL)-7-METHYLXANTHINE

      Journal of medicinal chemistry
    91. VEERANNA; REDDY PL; BHARGAVA HN
      EFFECT OF CHRONIC ADMINISTRATION OF U-50,488H, A KAPPA-OPIOID RECEPTOR AGONIST, ON CENTRAL DOPAMINE-D(2) RECEPTORS OF THE RAT

      European journal of pharmacology
    92. JIANG H; JACKSONLEWIS V; MUTHANE U; DOLLISON A; FERREIRA M; ESPINOSA A; PARSONS B; PRZEDBORSKI S
      ADENOSINE RECEPTOR ANTAGONISTS POTENTIATE DOPAMINE RECEPTOR AGONIST-INDUCED ROTATIONAL BEHAVIOR IN 6-HYDROXYDOPAMINE-LESIONED RATS

      Brain research
    93. MAZZONI MR; MARTINI C; LUCACCHINI A
      REGULATION OF AGONIST BINDING TO A(2A) ADENOSINE RECEPTORS - EFFECTS OF GUANINE-NUCLEOTIDES (GDP[S] AND GTP[S]) AND MG2+ ION

      Biochimica et biophysica acta


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 02/06/20 alle ore 23:05:35